-
Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances
prnasia
December 14, 2020
Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Platform.
-
RNA structures of coronavirus reveal potential drug targets
worldpharmanews
November 11, 2020
The SARS-CoV-2 coronavirus RNA genome structure was studied in detail by researchers from the University of Groningen, the International Institute of Molecular and Cell Biology in Warsaw, and Leiden University.
-
Magnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR
prnewswire
November 06, 2020
A team of scientist from Saint Vincent University Hospital, National Virus Reference Laboratory, University College Dublin, and Magnostics Ltd, announced at the Science Foundation of Ireland's 2020 Science Summit the development of viral RNA extraction ..
-
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study
expresspharma
September 23, 2020
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this virus so good at the process of infection.
-
GeneCentric Therapeutics signs research alliance with Janssen
pharmaceutical-technology
August 14, 2020
GeneCentric Therapeutics and Janssen Research & Development have formed a research alliance focused on RNA-based drug response biomarkers for non-muscle invasive bladder cancer (NMIBC).
-
IIT Mandi team compares disordered proteins in COVID-19 virus through computational studies
expresspharma
August 11, 2020
Understanding the structure and functions of intrinsically disordered proteins (IDPs), and intrinsically disordered protein regions (IDPR) in COVD-19 can help in finding ways to mitigate the effects of the infection, say researchers.
-
First patient dosed with COVID-19 vaccine using self-amplifying RNA
europeanpharmaceuticalreview
June 28, 2020
A Phase I clinical trial to test Imperial College London’s COVID-19 vaccine candidate has been initiated, with the first patient dosed.
-
Lilly signs up for access to Evox' tech in R&D deal
pharmatimes
June 16, 2020
Evox Therapeutics has signed a collaboration deal with Eli Lilly centred on brain/CNS disorders, which could net the latter around $1.2 billion in development, regulatory and commercial milestone payments.
-
NCVTC to develop host-directed antivirals for COVID 19
expresspharma
June 05, 2020
The selected candidates (hits) with anti-coronavirus activity will be subjected to study of their molecular mechanism of action, besides examining generation of potential drug-resistant virus variants.
-
Simple but effective: an experimental nanoparticle COVID-19 test
europeanpharmaceuticalreview
June 03, 2020
Researchers reveal their experimental test can detect the presence of COVID-19 RNA in a sample in 10 minutes, and in a way that does not require trained personnel to interpret.